Companies in the therapeutics sector developing innovative solutions and technologies.
Explore 1,733 recently funded therapeutics companies with verified founder contact information and fundraising data.
Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.
BioNxt Solutions mission is to develop and commercialize next-generation pharmaceuticals.
Osanni Bio is a biotechnology company developing therapies aimed at preventing and reversing blindness caused by retinal diseases.
TRIMTECH Therapeutics treats inflammatory and persistent CNS conditions by focusing on the elimination of harmful proteins.
Syntax Bio is a biotechnology company that develops a cell programming platform to control stem cell differentiation for research.
Replicate Bioscience develops self-replicating RNA therapeutics and vaccines delivering immunity at lower doses across multiple diseases.
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.
iQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.
Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.
Triveni Bio is a biotechnology company that develops antibody-based therapeutics for immunological and inflammatory diseases.
Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.
Sera Medicines is an operator of biologics accelerator developing and launching next-generation protein therapeutics.
FinalDose develops programmable DNA therapeutics that eliminate diseased cells by targeting pathogenic genetic sequences.
Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections through an AI-powered technology.
HMNC Brain Health is a precision medicine pioneer in psychiatry based in Munich.
Zumutor Biologics develops immuno-oncology therapies that harness the body's innate immune system to treat cancer.
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Beren Therapeutics is a biotechnology company that develops innovative therapies to make them accessible to every patient.
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
GT Medical Technologies develops medical technologies to improve outcomes for patients with brain tumors.
City Therapeutics is a biopharmaceutical company focused on developing RNA interference (RNAi)-based medicines for a range of diseases.
IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.
Goldenrod Therapeutics develops a small molecule to prevent pathogenic activity in immune cells.
The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 1,733 therapeutics companies tracked in the VCBacked database.
Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked